JP2015514072A5 - - Google Patents

Download PDF

Info

Publication number
JP2015514072A5
JP2015514072A5 JP2015501784A JP2015501784A JP2015514072A5 JP 2015514072 A5 JP2015514072 A5 JP 2015514072A5 JP 2015501784 A JP2015501784 A JP 2015501784A JP 2015501784 A JP2015501784 A JP 2015501784A JP 2015514072 A5 JP2015514072 A5 JP 2015514072A5
Authority
JP
Japan
Prior art keywords
fluoro
phenyl
indazol
acrylic acid
vinyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015501784A
Other languages
English (en)
Japanese (ja)
Other versions
JP6154887B2 (ja
JP2015514072A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2013/031507 external-priority patent/WO2013142266A1/en
Publication of JP2015514072A publication Critical patent/JP2015514072A/ja
Publication of JP2015514072A5 publication Critical patent/JP2015514072A5/ja
Application granted granted Critical
Publication of JP6154887B2 publication Critical patent/JP6154887B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015501784A 2012-03-20 2013-03-14 エストロゲン受容体モジュレーターおよびその使用 Active JP6154887B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261613442P 2012-03-20 2012-03-20
US61/613,442 2012-03-20
PCT/US2013/031507 WO2013142266A1 (en) 2012-03-20 2013-03-14 Estrogen receptor modulators and uses thereof

Publications (3)

Publication Number Publication Date
JP2015514072A JP2015514072A (ja) 2015-05-18
JP2015514072A5 true JP2015514072A5 (enExample) 2017-02-09
JP6154887B2 JP6154887B2 (ja) 2017-06-28

Family

ID=49223229

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015501784A Active JP6154887B2 (ja) 2012-03-20 2013-03-14 エストロゲン受容体モジュレーターおよびその使用

Country Status (17)

Country Link
US (1) US9499538B2 (enExample)
EP (1) EP2828243B1 (enExample)
JP (1) JP6154887B2 (enExample)
KR (1) KR20140138296A (enExample)
CN (1) CN104220426B (enExample)
AU (1) AU2013235499A1 (enExample)
CA (1) CA2866891A1 (enExample)
CO (1) CO7170179A2 (enExample)
CR (1) CR20140479A (enExample)
EA (1) EA201491530A1 (enExample)
IL (1) IL234487A0 (enExample)
MX (1) MX2014011217A (enExample)
NZ (1) NZ630124A (enExample)
PE (1) PE20142461A1 (enExample)
PH (1) PH12014502095A1 (enExample)
SG (1) SG11201405918XA (enExample)
WO (1) WO2013142266A1 (enExample)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9499538B2 (en) 2012-03-20 2016-11-22 Seragon Pharmaceuticals, Inc. Estrogen receptor modulators and uses thereof
CN105121413B (zh) 2013-03-14 2018-09-14 赛拉根医药股份有限公司 多环雌激素受体调节剂及其用途
SG11201507459YA (en) 2013-03-15 2015-10-29 Epigen Biosciences Inc Heterocyclic compounds useful in the treatment of disease
EA031077B1 (ru) 2013-06-19 2018-11-30 Серагон Фармасьютикалз, Инк. Модулятор рецептора эстрогена и его применения
BR112015030595A2 (pt) 2013-06-19 2017-07-25 Seragon Pharmaceuticals Inc moduladores de receptor de estrogênio de azetidina e usos dos mesmos
MX2016007282A (es) 2013-12-06 2016-09-07 Hoffmann La Roche Modulador del receptor de estrogenos para el tratamiento de cancer de mama positivo al receptor de estrogenos localmente avanzado o metastasico.
MA39740A (fr) * 2014-03-13 2017-01-18 Hoffmann La Roche Méthodes et compositions pour moduler des mutants du récepteur des oestrogènes
SG11201607334YA (en) 2014-03-13 2016-10-28 Hoffmann La Roche Therapeutic combinations with estrogen receptor modulators
SG11201700995WA (en) 2014-08-11 2017-03-30 Hoffmann La Roche Crystalline forms of an estrogen receptor modulator
JP6768711B2 (ja) 2015-05-26 2020-10-14 エフ・ホフマン−ラ・ロシュ・アクチェンゲゼルシャフト 複素環式エストロゲン受容体モジュレーター及びその使用
RS62481B1 (sr) 2015-05-29 2021-11-30 Eisai R&D Man Co Ltd Jedinjenja tetrasupstituisanog alkena i njihova upotreba
CN105061316B (zh) * 2015-07-17 2017-12-22 苏州大学 稠环类化合物、制备方法和用途
CN106518768B (zh) * 2015-09-15 2021-07-02 江苏恒瑞医药股份有限公司 丙烯酸类衍生物、其制备方法及其在医药上的应用
CN108137511A (zh) * 2015-10-07 2018-06-08 豪夫迈·罗氏有限公司 制备(e)-3-(4-((e)-2-(2-氯-4-氟苯基)-1-(1h-吲唑-5-基)丁-1-烯-1-基)苯基)丙烯酸的方法
DK3386500T3 (da) 2015-12-09 2022-12-12 Univ Illinois Benzothiophen-baserede selektive østrogenreceptor ned-regulatorer
WO2017162206A1 (zh) * 2016-03-25 2017-09-28 南京明德新药研发股份有限公司 作为雌激素受体降解剂的吲哚并取代哌啶类化合物
KR20220071293A (ko) 2016-04-01 2022-05-31 리커리엄 아이피 홀딩스, 엘엘씨 에스트로겐 수용체 조절제
CN113912586B (zh) 2016-08-31 2023-04-07 江苏恒瑞医药股份有限公司 氧代吡啶酰胺类衍生物、其制备方法及其在医药上的应用
WO2018081168A2 (en) 2016-10-24 2018-05-03 The Board Of Trustees Of The University Of Illinois Benzothiophene-based selective mixed estrogen receptor downregulators
JP2019535778A (ja) * 2016-11-24 2019-12-12 エーザイ・アール・アンド・ディー・マネジメント株式会社 四置換アルケン化合物及び乳がんを治療するためのその使用
CN109790141B (zh) 2016-11-28 2021-06-11 卫材 R&D 管理有限公司 吲唑衍生物的盐及其晶体
JP7229162B2 (ja) 2017-01-06 2023-02-27 ジー1 セラピューティクス, インコーポレイテッド 癌の治療に対する併用療法
KR20190117582A (ko) 2017-02-10 2019-10-16 쥐원 쎄라퓨틱스, 인크. 벤조티오펜 에스트로겐 수용체 조정제
CN108976187B (zh) * 2017-06-02 2021-11-26 上海青东生物科技有限公司 一种取代苯并呋喃衍生物及其制备与在制备抗肿瘤药物中的应用
WO2019225552A1 (en) * 2018-05-22 2019-11-28 Eisai R&D Management Co., Ltd. Salts of indazole derivative and crystals thereof
AU2019321588C1 (en) 2018-08-17 2026-05-14 Genentech, Inc. Diagnostic and therapeutic methods for the treatment of breast cancer
AU2019400398B2 (en) * 2018-12-17 2024-10-03 Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Estrogen receptor antagonist
US12325696B2 (en) * 2019-06-19 2025-06-10 Jiangsu Hengrui Medicine Co., Ltd. Indazole derivative, preparation method therefor, and pharmaceutical application thereof
JP2022543832A (ja) 2019-08-06 2022-10-14 リキュリウム アイピー ホールディングス リミテッド ライアビリティー カンパニー 変異体を治療するためのエストロゲン受容体調節剤
EP4267578A4 (en) 2020-12-23 2024-11-20 Recurium IP Holdings, LLC ESTROGEN RECEPTOR MODULATORS
CN115745895A (zh) * 2021-11-13 2023-03-07 温州奥洋科技有限公司 一种紫外线吸收剂二苯嘧啶乙烯的结构与合成路线
CN116239562B (zh) * 2021-12-07 2024-12-31 江苏师范大学 一种以苯并呋喃酮为原料合成盐酸多塞平的方法

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0002097B1 (en) 1977-08-22 1981-08-05 Imperial Chemical Industries Plc Triphenylalkene derivatives, process for their preparation and pharmaceutical compositions containing them
US4229447A (en) 1979-06-04 1980-10-21 American Home Products Corporation Intraoral methods of using benzodiazepines
US4596795A (en) 1984-04-25 1986-06-24 The United States Of America As Represented By The Secretary, Dept. Of Health & Human Services Administration of sex hormones in the form of hydrophilic cyclodextrin derivatives
US5011692A (en) 1985-12-28 1991-04-30 Sumitomo Pharmaceuticals Company, Limited Sustained pulsewise release pharmaceutical preparation
US4755386A (en) 1986-01-22 1988-07-05 Schering Corporation Buccal formulation
US5052558A (en) 1987-12-23 1991-10-01 Entravision, Inc. Packaged pharmaceutical product
US5033252A (en) 1987-12-23 1991-07-23 Entravision, Inc. Method of packaging and sterilizing a pharmaceutical product
US5739136A (en) 1989-10-17 1998-04-14 Ellinwood, Jr.; Everett H. Intraoral dosing method of administering medicaments
US5017381A (en) 1990-05-02 1991-05-21 Alza Corporation Multi-unit pulsatile delivery system
US5229135A (en) 1991-11-22 1993-07-20 Prographarm Laboratories Sustained release diltiazem formulation
US5323907A (en) 1992-06-23 1994-06-28 Multi-Comp, Inc. Child resistant package assembly for dispensing pharmaceutical medications
JP3409366B2 (ja) 1993-06-18 2003-05-26 東洋インキ製造株式会社 有機エレクトロルミネッセンス素子
US5681835A (en) 1994-04-25 1997-10-28 Glaxo Wellcome Inc. Non-steroidal ligands for the estrogen receptor
US5837284A (en) 1995-12-04 1998-11-17 Mehta; Atul M. Delivery of multiple doses of medications
DE19807760A1 (de) 1997-02-27 1998-09-03 Fuji Electric Co Ltd Elektrofotografischer Fotoleiter
US5840329A (en) 1997-05-15 1998-11-24 Bioadvances Llc Pulsatile drug delivery system
CN1275911A (zh) 1997-08-15 2000-12-06 杜克大学 一种预防或治疗雌激素依赖性疾病及失调的方法
DE19801597C2 (de) 1998-01-17 2001-05-03 Aventis Res & Tech Gmbh & Co Basenkatalysierte Synthese von 1-Aryl-4-(arylethyl)piperazinen aus aromatischen Olefinen und 1-Arylpiperazinen
DE19801598C2 (de) 1998-01-17 2000-05-11 Aventis Res & Tech Gmbh & Co Katalytische Synthese von N-alkylierten Anilinen aus Olefinen und Anilinen
TW593256B (en) 1999-11-16 2004-06-21 Hormos Medical Oy Ltd Triphenylalkene derivatives and their use as selective estrogen receptor modulators
GB9929988D0 (en) 1999-12-17 2000-02-09 Celltech Therapeutics Ltd Chemical compounds
US6528681B2 (en) 2000-04-05 2003-03-04 Bristol-Meyers Squibb Pharma Company Halogenated triphenylethylene derivatives as selective estrogen receptor modulators
EP1417169A2 (en) * 2001-08-11 2004-05-12 Bristol-Myers Squibb Pharma Company Selective estrogen receptor modulators
US7414040B2 (en) 2002-06-06 2008-08-19 Smithkline Beecham Corporation Thrombopoietin mimetics
EP1692127B1 (en) * 2003-10-08 2008-07-02 Smithkline Beecham Corporation Triphenylethylene compounds as selective estrogen receptor modulators
DE102004028862A1 (de) * 2004-06-15 2005-12-29 Merck Patent Gmbh 3-Aminoindazole
US20070292545A1 (en) 2005-10-18 2007-12-20 Aaron Monte Anti-infective agents and methods of use
US7528132B2 (en) * 2005-01-26 2009-05-05 Schering Corporation Kinase inhibitors
JP2009504872A (ja) 2005-08-15 2009-02-05 テクニオン リサーチ アンド ディベロップメント ファウンデーション リミテッド 印刷可能な材料
JP2010508358A (ja) 2006-11-01 2010-03-18 ブリストル−マイヤーズ スクイブ カンパニー グルココルチコイド受容体、AP−1、および/またはNF−κB活性の調節剤、並びにその使用
JP2008156313A (ja) 2006-12-26 2008-07-10 Fyuuensu:Kk アミロイド疾患の治療およびモニタリングのための薬剤
GB0704407D0 (en) 2007-03-07 2007-04-18 Glaxo Group Ltd Compounds
DE102007049451A1 (de) * 2007-10-16 2009-04-23 Merck Patent Gmbh 5-Cyano-thienopyridine
JP5223362B2 (ja) 2008-02-07 2013-06-26 コニカミノルタビジネステクノロジーズ株式会社 光電変換素子及び太陽電池
WO2009131654A2 (en) 2008-04-21 2009-10-29 North Carolina State University Inhibition and dispersion of bacterial biofilms with imidazole-triazole derivatives
AR074199A1 (es) 2008-11-20 2010-12-29 Glaxosmithkline Llc Compuesto de 6-(4-pirimidinil)-1h-indazol, composiciones farmaceuticas que lo comprenden y su uso para preparar un medicamento util para el tratamiento o disminucion de la gravedad del cancer.
WO2010077603A1 (en) 2008-12-08 2010-07-08 North Carolina State University Inhibition and dispersion of biofilms in plants with imidazole-triazole derivatives
WO2010107474A1 (en) 2009-03-16 2010-09-23 The Research Foundation Of State University Of New York Antiestrogens for breast cancer therapy
WO2010144959A1 (en) 2009-06-18 2010-12-23 Fibrotech Therapeutics Pty Ltd Analogues of anti-fibrotic agents
GB2483736B (en) * 2010-09-16 2012-08-29 Aragon Pharmaceuticals Inc Estrogen receptor modulators and uses thereof
US9499538B2 (en) 2012-03-20 2016-11-22 Seragon Pharmaceuticals, Inc. Estrogen receptor modulators and uses thereof
JP6126562B2 (ja) * 2014-08-27 2017-05-10 三星ダイヤモンド工業株式会社 光ファイバ装置

Similar Documents

Publication Publication Date Title
JP2014531465A5 (enExample)
JP2014528446A5 (enExample)
RU2015132181A (ru) Фтор-[1,3]-оксазины в качестве ингибиторов васе1
AU2018201953A1 (en) Certain amino-pyridazines, compositions thereof, and methods of their use
JP2014518214A5 (enExample)
JP2016512259A5 (enExample)
HRP20160539T1 (hr) Antagonisti trpv4
JP2014525444A5 (enExample)
RU2021129721A (ru) Пирролопиримидины в качестве потенциаторов мвтр
JP2017528519A5 (enExample)
JP2009541311A5 (enExample)
JP2012508223A5 (enExample)
JP2018535999A5 (enExample)
JP2016514719A5 (enExample)
JP2020536116A5 (enExample)
EA018721B1 (ru) Модуляторы сигнального пути hedgehog
RU2012133475A (ru) Ингибиторы кинуренин-3-монооксигеназы, фармацевтические композиции и способы их применения
RU2016133684A (ru) Бициклические азот-содержащие соединения как агонисты М1 мускариновых рецепторов
TW201917126A (zh) 二氫二酮
JP2020529419A5 (enExample)
JP2020503293A5 (enExample)
JP2019508400A5 (enExample)
JP2018511613A5 (enExample)
JP7554492B2 (ja) フェニルイミダゾール化合物
RU2017134884A (ru) Ингибиторы бета-секретазы